{
     "PMID": "24769309",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20150126",
     "LR": "20151119",
     "IS": "1873-5177 (Electronic) 0091-3057 (Linking)",
     "VI": "122",
     "DP": "2014 Jul",
     "TI": "Atorvastatin evokes a serotonergic system-dependent antidepressant-like effect in mice.",
     "PG": "253-60",
     "LID": "10.1016/j.pbb.2014.04.005 [doi] S0091-3057(14)00113-0 [pii]",
     "AB": "Atorvastatin is a statin largely used in the treatment of hypercholesterolemia and recently revealed as a neuroprotective agent. The antidepressant-like effect of acute atorvastatin treatment in mice has been previously demonstrated by our laboratory. The purpose of this study was to explore the contribution of the serotonergic system in the antidepressant-like effect of atorvastatin in mice. Data demonstrate that the serotonin (5-HT) depleting agent p-chlorophenylalanine methyl ester (PCPA, 100 mg/kg, i.p.) completely abolished atorvastatin (0.1 mg/kg, p.o.) antidepressant-like effect. Besides atorvastatin, fluoxetine (10 mg/kg, p.o.), a serotonin selective reuptake inhibitor (SSRI) was able to exert an antidepressant-like effect, but any of them changed 5-HT content in the hippocampus or frontal cortex. The 5H-T1A (WAY100635, 0.1 mg/kg, s.c) or the 5-HT2A/2C (ketanserin, 5 mg/kg, s.c.) receptor antagonists prevented atorvastatin antidepressant-like effect. In addition, a combinatory antidepressant-like effect was observed when mice received the co-administration of sub-effective doses of atorvastatin (0.01 mg/kg, p.o.) and the SSRI fluoxetine (5 mg/kg, p.o.), paroxetine (0.1 mg/kg, p.o.) or sertraline (1 mg/kg, p.o.). Taken together, these results indicate that the antidepressant-like effect of atorvastatin depends on the serotonergic system modulation.",
     "CI": [
          "Copyright (c) 2014 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Ludka, Fabiana K",
          "Constantino, Leandra Celso",
          "Kuminek, Gislaine",
          "Binder, Luisa Bandeira",
          "Zomkowski, Andrea D E",
          "Cunha, Mauricio P",
          "Dal-Cim, Tharine",
          "Rodrigues, Ana Lucia S",
          "Tasca, Carla I"
     ],
     "AU": [
          "Ludka FK",
          "Constantino LC",
          "Kuminek G",
          "Binder LB",
          "Zomkowski AD",
          "Cunha MP",
          "Dal-Cim T",
          "Rodrigues AL",
          "Tasca CI"
     ],
     "AD": "Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade 88040-900, Florianopolis, SC, Brazil; Curso de Farmacia, Universidade do Contestado, 89460-000 Canoinhas, SC, Brazil. Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade 88040-900, Florianopolis, SC, Brazil. Programa de Pos-graduacao em Farmacia, Centro de Ciencias da Saude, Universidade Federal de Santa Catarina, Trindade 88040-900, Florianopolis, SC, Brazil. Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade 88040-900, Florianopolis, SC, Brazil. Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade 88040-900, Florianopolis, SC, Brazil. Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade 88040-900, Florianopolis, SC, Brazil. Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade 88040-900, Florianopolis, SC, Brazil. Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade 88040-900, Florianopolis, SC, Brazil. Departamento de Bioquimica, Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Trindade 88040-900, Florianopolis, SC, Brazil. Electronic address: carla.tasca@ufsc.br.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20140421",
     "PL": "United States",
     "TA": "Pharmacol Biochem Behav",
     "JT": "Pharmacology, biochemistry, and behavior",
     "JID": "0367050",
     "RN": [
          "0 (Antidepressive Agents)",
          "0 (Heptanoic Acids)",
          "0 (Pyrroles)",
          "0 (Receptors, Serotonin)",
          "0 (Serotonin Antagonists)",
          "333DO1RDJY (Serotonin)",
          "48A5M73Z4Q (Atorvastatin Calcium)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antidepressive Agents/pharmacology/*therapeutic use",
          "Atorvastatin Calcium",
          "Brain/drug effects/*metabolism",
          "Depression/*drug therapy/*metabolism",
          "Heptanoic Acids/pharmacology/*therapeutic use",
          "Male",
          "Mice",
          "Pyrroles/pharmacology/*therapeutic use",
          "Receptors, Serotonin/metabolism",
          "Serotonin/*metabolism",
          "Serotonin Antagonists/pharmacology",
          "Treatment Outcome"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Antidepressant-like effect",
          "Atorvastatin",
          "Serotonergic system",
          "Serotonin",
          "Statin",
          "Tail suspension test"
     ],
     "EDAT": "2014/04/29 06:00",
     "MHDA": "2015/01/27 06:00",
     "CRDT": [
          "2014/04/29 06:00"
     ],
     "PHST": [
          "2014/02/10 00:00 [received]",
          "2014/04/05 00:00 [revised]",
          "2014/04/12 00:00 [accepted]",
          "2014/04/29 06:00 [entrez]",
          "2014/04/29 06:00 [pubmed]",
          "2015/01/27 06:00 [medline]"
     ],
     "AID": [
          "S0091-3057(14)00113-0 [pii]",
          "10.1016/j.pbb.2014.04.005 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Pharmacol Biochem Behav. 2014 Jul;122:253-60. doi: 10.1016/j.pbb.2014.04.005. Epub 2014 Apr 21.",
     "term": "hippocampus"
}